Loki Therapeutics Forms Scientific Advisory Board to Advance Development of “Childhood Vaccination”-Based Cancer Therapeutics
LONG ISLAND CITY, N.Y., June 15, 2020 /PRNewswire/ — Loki Therapeutics, an immuno-oncology company developing next-generation cancer therapeutics that leverage childhood vaccination recall antigens, today announced the formation of its Scientific Advisory Board (SAB), and the appointment…
Comments Off on Loki Therapeutics Forms Scientific Advisory Board to Advance Development of “Childhood Vaccination”-Based Cancer Therapeutics